📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. (2015)

First Author: Dolman ME

Attributed to: Multimodality Techniques for Cancer Diagnosis and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-15-0313

PubMed Identifier: 26202950

Publication URI: http://europepmc.org/abstract/MED/26202950

Type: Journal Article/Review

Volume: 21

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 22

ISSN: 1078-0432